Management of Reflux Symptoms with Over-the-Counter Proton Pump Inhibitors: Issues and Proposed Guidelines
Authors:
Open Access
- 16 October 2009
- journal article
- review article
- Published by S. Karger AG in Digestion
- Vol. 80 (4) , 226-234
Abstract
Background: Symptoms of gastroesophageal reflux are widely prevalent. There is a continuum between subjects with mild reflux symptoms and those severely affected by gastroesophageal reflux disease (GERD). Both groups may at times access over-the-counter (OTC) therapies. For the purpose of this review, relevant papers, including national and international guidelines were reviewed and recommendations made for appropriate use of OTC proton pump inhibitor (PPI) therapy. Results: PPIs are the gold standard for treatment of reflux symptoms. OTC therapy with histamine2 receptor antagonists (H2RAs) also plays a role. For the majority affected by reflux symptoms, effective symptom control is the most important outcome, as only a subgroup requires investigations or interventions. However, patients with alarm features (i.e. troublesome dysphagia, weight loss, predominant upper abdominal pain) are not recommended for OTC therapy and need prompt medical referral. Frequent relapses or failure to adequately respond to OTC therapy are additional triggers for medical assessment. Conclusions: OTC treatment of typical reflux symptoms (acid regurgitation, heartburn) with antacids and H2RAs is now accepted as safe and results in short-term relief of symptoms. There is no evidence of additional risk with OTC PPIs compared to these existing OTC therapies and PPIs are significantly more efficacious.Keywords
This publication has 34 references indexed in Scilit:
- Empiric PPI therapy or endoscopy for the initial management of patients with GERD in the absence of alarm features?Nature Clinical Practice Gastroenterology & Hepatology, 2008
- Prevalence of Barrett’s Esophagus in Patients with or without GERD Symptoms: Role of Race, Age, and GenderDigestive Diseases and Sciences, 2008
- Systematic Review on Epidemiology of Gastroesophageal Reflux Disease in AsiaClinical Gastroenterology and Hepatology, 2006
- Risk of Community-Acquired Pneumonia and Use of Gastric Acid–Suppressive DrugsJAMA, 2004
- The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment – Prompt Endoscopy (CADET–PE) studyAlimentary Pharmacology & Therapeutics, 2003
- Gastro‐oesophageal reflux disease in adults: Guidelines for cliniciansJournal of Gastroenterology and Hepatology, 2002
- Epidemiology and natural history of reflux diseaseBest Practice & Research Clinical Gastroenterology, 2000
- Gastro‐oesophageal reflux disease in AsiaJournal of Gastroenterology and Hepatology, 2000
- Use of Antacids in a General Population: The Impact of Health-Related Variables, Lifestyle and Sociodemographic CharacteristicsJournal of Clinical Epidemiology, 1999
- Prevalence of Barrett's Esophagus in Hispanics Is Similar to CaucasiansDigestive Diseases and Sciences, 1998